R H Gelber

3.4k total citations
81 papers, 2.0k citations indexed

About

R H Gelber is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, R H Gelber has authored 81 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Infectious Diseases, 52 papers in Epidemiology and 25 papers in Surgery. Recurrent topics in R H Gelber's work include Leprosy Research and Treatment (63 papers), Mycobacterium research and diagnosis (47 papers) and Infectious Diseases and Tuberculosis (23 papers). R H Gelber is often cited by papers focused on Leprosy Research and Treatment (63 papers), Mycobacterium research and diagnosis (47 papers) and Infectious Diseases and Tuberculosis (23 papers). R H Gelber collaborates with scholars based in United States, Japan and United Kingdom. R H Gelber's co-authors include S W Hunter, Patrick J. Brennan, Rodolfo M. Abalos, Bonnie B. Plikaytis, Thomas M. Shinnick, S N Cho, Donna Yanagihara, G. R. Gordon, J. H. Peters and Anthony J. Glazko and has published in prestigious journals such as The Journal of Immunology, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

R H Gelber

78 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R H Gelber United States 27 1.5k 1.2k 731 259 165 81 2.0k
Yuka Sasaki Japan 19 1.1k 0.7× 1.0k 0.8× 589 0.8× 116 0.4× 75 0.5× 71 1.7k
M D Iseman United States 18 1.1k 0.7× 998 0.8× 498 0.7× 182 0.7× 37 0.2× 33 1.5k
Powel Kazanjian United States 27 1.0k 0.7× 1.1k 0.8× 237 0.3× 177 0.7× 24 0.1× 64 1.9k
Sang Nae Cho South Korea 15 1.1k 0.7× 828 0.7× 359 0.5× 405 1.6× 37 0.2× 28 1.4k
Philip Noël Suffys Brazil 30 2.1k 1.4× 2.0k 1.6× 1.0k 1.4× 303 1.2× 142 0.9× 127 2.6k
Ward E. Bullock United States 28 992 0.6× 1.1k 0.9× 265 0.4× 242 0.9× 103 0.6× 72 2.2k
Luís F. López‐Cortés Spain 29 1.4k 0.9× 1.5k 1.2× 217 0.3× 162 0.6× 49 0.3× 155 2.8k
Margaret Burroughs United States 31 1.1k 0.7× 2.7k 2.2× 215 0.3× 326 1.3× 46 0.3× 92 4.0k
Ralph Tompsett United States 18 935 0.6× 812 0.7× 264 0.4× 292 1.1× 61 0.4× 46 1.5k
G Canetti France 15 1.6k 1.1× 1.4k 1.1× 673 0.9× 228 0.9× 39 0.2× 53 1.8k

Countries citing papers authored by R H Gelber

Since Specialization
Citations

This map shows the geographic impact of R H Gelber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R H Gelber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R H Gelber more than expected).

Fields of papers citing papers by R H Gelber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R H Gelber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R H Gelber. The network helps show where R H Gelber may publish in the future.

Co-authorship network of co-authors of R H Gelber

This figure shows the co-authorship network connecting the top 25 collaborators of R H Gelber. A scholar is included among the top collaborators of R H Gelber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R H Gelber. R H Gelber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgos, Jasmin, et al.. (2009). Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy. Leprosy Review. 80(2). 205–209. 5 indexed citations
2.
Burgos, Jasmin, et al.. (2008). Powerful Bactericidal Activity of Moxifloxacin in Human Leprosy. Antimicrobial Agents and Chemotherapy. 52(9). 3113–3117. 32 indexed citations
3.
Matsuoka, Masanori, Khin Saw Aye, Kyaw Kyaw, et al.. (2008). A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries. Journal of Medical Microbiology. 57(10). 1213–1219. 20 indexed citations
4.
Fajardo, T. T., et al.. (2007). Methods for the Classification of Leprosy for Treatment Purposes. Clinical Infectious Diseases. 44(8). 1096–1099. 65 indexed citations
5.
Fajardo, Tranquilino T., Laarni G. Villahermosa, Eduardo Canteiro Cruz, et al.. (2004). A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy. Leprosy Review. 75(4). 389–397. 17 indexed citations
6.
Cellona, Roland V., Eduardo Canteiro Cruz, Jasmin Burgos, et al.. (2003). Long-term Efficacy of 2 Year WHO Multiple Drug Therapy (MDT) in Multibacillary (MB) Leprosy Patients. PubMed. 71(4). 308–308. 42 indexed citations
7.
Gelber, R H. (1994). Chemotherapy of lepromatous leprosy: Recent developments and prospects for the future. European Journal of Clinical Microbiology & Infectious Diseases. 13(11). 942–952. 13 indexed citations
8.
9.
Gelber, R H, et al.. (1993). Roles of Soluble Fibronectin and β1 Integrin Receptors in the Binding of Mycobacterium leprae to NaSal Epithelial Cells. Clinical Immunology and Immunopathology. 69(3). 266–271. 26 indexed citations
10.
Gelber, R H, et al.. (1992). A clinical trial of minocycline in lepromatous leprosy.. BMJ. 304(6819). 91–92. 42 indexed citations
11.
Williams, Diana L., et al.. (1992). Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Molecular and Cellular Probes. 6(5). 401–410. 29 indexed citations
12.
Gelber, R H. (1991). The Activity of Amoxicillin plus Clavulanic Acid against Mycobacterium leprae in Mice. The Journal of Infectious Diseases. 163(6). 1374–1377. 3 indexed citations
13.
Byrd, Sharon E. & R H Gelber. (1991). Effect of dapsone on haemoglobin concentration in patients with leprosy. Leprosy Review. 62(2). 171–8. 30 indexed citations
14.
Gelber, R H. (1990). Primary Dapsone-Resistant Hansen's Disease in California. Archives of Dermatology. 126(12). 1584–1584. 3 indexed citations
15.
Gelber, R H. (1990). Progress in the chemotherapy of leprosy: Status, issues and prospects. Birkhäuser Basel eBooks. 34. 421–445. 7 indexed citations
16.
Gelber, R H. (1990). Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates. Archives of Dermatology. 126(12). 1584–1586. 7 indexed citations
17.
Gelber, R H. (1987). Activity of Minocycline in Mycobacterium leprae--Infected Mice. The Journal of Infectious Diseases. 156(1). 236–239. 50 indexed citations
18.
Gelber, R H. (1986). Minocycline studies in mice of a promising agent for the treatment of leprosy. 54(4). 722–723. 2 indexed citations
19.
Hunter, S W, et al.. (1986). Quantitation of the Phenolic Glycolipid of Mycobacterium leprae and Relevance to Glycolipid Antigenemia in Leprosy. The Journal of Infectious Diseases. 153(3). 560–569. 37 indexed citations
20.
Gelber, R H, Michael F. Waters, J. M. H. Pearson, A. C. McDOUGALL, & R. J. W. Rees. (1976). Persisting mycobacterium leprae after dapsone plus rifampin treatment of lepromatous leprosy. 44(4). 548–549. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuka Sasaki Breakdown of academic impact, for papers by M D Iseman Breakdown of academic impact, for papers by Powel Kazanjian Breakdown of academic impact, for papers by Sang Nae Cho Breakdown of academic impact, for papers by Philip Noël Suffys Breakdown of academic impact, for papers by Ward E. Bullock Breakdown of academic impact, for papers by Luís F. López‐Cortés Breakdown of academic impact, for papers by Margaret Burroughs Breakdown of academic impact, for papers by Ralph Tompsett Breakdown of academic impact, for papers by G Canetti
Rankless by CCL
2026